DTL
NXTC icon

Dynamic Technology Lab’s NextCure NXTC Stock Holding History

Dynamic Technology Lab’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,098
Closed -$132K – 1395
2021
Q1 		$132K Buy
+1,098
New +$159K 0.01% 1010
2020
Q4 		– Sell
-948
Closed -$100K – 1242
2020
Q3 		$100K Buy
+948
New +$117K 0.02% 891

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dynamic Technology Lab's NXTC Position: Q2 2021 in Review

Dynamic Technology Lab sold out of NextCure (NXTC) in Q2 2021, closing a stake of 1,098 shares — an estimated $132K sold.

Dynamic Technology Lab first reported a position in NXTC in Q3 2020 and held it in 2 quarters. The position peaked at $132K in Q1 2021. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Dynamic Technology Lab reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,098 NextCure shares in Q2 2021, an estimated $132K.
  • Dynamic Technology Lab first reported a position in NextCure in Q3 2020 and held it in 2 quarters.
  • Dynamic Technology Lab's NextCure position peaked at $132K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Dynamic Technology Lab's 13F filing for Q2 2021, filed 13 Aug 2021.